Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1431]

Pembrolizumab label updated with new clinical trial information in melanoma

Pembrolizumab label updated with new clinical trial information in melanoma

BAP1 mutation passed down over centuries and is associated with high incidence of several cancers

BAP1 mutation passed down over centuries and is associated with high incidence of several cancers

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

Immunotherapy and targeted therapy provide new options for difficult-to-treat head and neck cancer

Talimogene laherparepvec approved for unresectable melanoma

Talimogene laherparepvec approved for unresectable melanoma

Research reveals promising novel strategy to target cancer-causing protein

Research reveals promising novel strategy to target cancer-causing protein

Study uncovers hard-to-detect cancer mutations

Study uncovers hard-to-detect cancer mutations

Nanotech drug delivery shows promise for improved melanoma treatment

Nanotech drug delivery shows promise for improved melanoma treatment

European cancer centres finally united in long-term collaborative partnerships

European cancer centres finally united in long-term collaborative partnerships

Scientists identify promising new melanoma drug

Scientists identify promising new melanoma drug

Positive opinion for orphan drug designation for avelumab in merkel cell carcinoma from ema committee for orphan medicinal products

Positive opinion for orphan drug designation for avelumab in merkel cell carcinoma from ema committee for orphan...

More from ecancer